Physician profile
Mark A Panigutti
NPI 1558369330
$4,104.34
in general payments reported to CMS, 2019-2025
13 companies · $414 in 2025
The $414 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $1,968 · 2021: $378 · 2022: $168 · 2023: $238 · 2024: $194 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,156.27 | 2019-2025 | Mako, Triathlon |
| Horizon Therapeutics Plc | $874.09 | 2019-2022 | |
| Depuy Synthes Sales INC. | $398.46 | 2019-2025 | Orthovisc, Monovisc |
| Smith+Nephew, INC. | $156.40 | 2022-2025 | Journey II, Legion Revision, Anthology |
| Rock Medical Orthopedics, INC. | $142.37 | 2020-2023 | |
| Zimmer Biomet Holdings, INC. | $115.08 | 2023 | Rosa |
| Carbofix Orthopedics INC | $113.56 | 2019 | |
| Bioventus LLC | $46.28 | 2021-2022 | |
| Fidia Pharma USA INC. | $32.65 | 2019-2024 | Hyalgan, Hymovis, Triluron |
| Next Science LLC | $21.50 | 2025 | Blastx, Xperience |
| Organogenesis INC. | $19.58 | 2020 | |
| Ethicon US, LLC | $15.77 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Panigutti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.